DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• DNA Topoisomerase II (Top2) is crucial for DNA management and a target for anticancer drugs like anthracyclines.
• The precise drug-binding site on Top2 remains unknown, hindering drug development.
• Top2 mutations offer insights into drug interactions and resistance mechanisms.

Purpose of the Study:

• To elucidate the molecular interactions between anthracyclines and DNA Topoisomerase II.
• To identify the specific drug receptor site on Top2.
• To provide a structural basis for understanding anthracycline activity and resistance.

Main Methods:

• Review of published crystal structures of Top2 (eukaryotic and prokaryotic).
• Analysis of biochemical data on Top2 activity and anthracycline interactions.
• Reconstruction of a molecular model of Top2-DNA complex post-cleavage.
• Integration of data from Top2 mutations affecting drug sensitivity.

Main Results:

• A molecular model identified the anthracycline receptor site on Top2.
• The model suggests drugs interact with cleaved DNA and the enzyme's CAP-like domain.
• This interaction explains known structure-activity relationships for antitumour anthracyclines.

Conclusions:

• The study proposes a model for anthracycline binding to DNA Topoisomerase II.
• This model clarifies drug-target interactions and resistance mechanisms.
• Findings provide a foundation for designing novel Top2-targeting anticancer agents.